
Tunisia: UNIMED increases Q1 revenue by 2% to 33 million dinars
Pharmaceutical company UNIMED continues its positive performance in 2025, reporting a **Q1 revenue of 33.3 million dinars, marking a 2% increase compared to the 32.8 million dinars recorded during the same period in 2024. This growth was driven by a 17% …